Skip to content

Clinical trials

Phase 1/2 Hearing Loss trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hearing Loss Phase: Phase 1/2 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20171
20181
20191
20201
20231
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed3
Not yet recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akouos, Inc.1
Contineum Therapeutics1
George Washington University1
Otonomy, Inc.1
Regeneron Pharmaceuticals1
Skylark Bio Inc.1
Sound Pharmaceuticals, Incorporated1
University of Arizona1
University of Colorado, Denver1
University of Kansas Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hearing Loss11
Hearing Loss, Sensorineural5
Hearing Loss, Hidden3
Deafness2
Hearing Disorders2
Hearing Loss, Noise-Induced2
Acidosis, Lactic1
Anxiety Disorders1
Auditory Diseases, Central1
Cognition Disorders1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.